Advanced search
Publication Cover
HIV Clinical Trials Volume 7, 2006 - Issue 4
Submit an article Journal homepage
98
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Cost-Effectiveness Analysis Comparing Chemotherapy Regimens in the Treatment of AIDS-Related Kaposi’s Sarcoma in Brazil

Tazio VanniFaculty of Medicine of Ribeirão PretoUniversity of São Paulo, São Paulo, Brazil
,
Benedito Antonio Lopes FonsecaFaculty of Medicine of Ribeirão PretoUniversity of São Paulo, São Paulo, Brazil
&
Carisi Anne PolanczykFaculty of MedicineFederal University of Rio Grande do Sul, Porto Alegre, BrazilCorrespondence[email protected]
Pages 194-202 | Published online: 14 Jan 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Karina Raimundo, Joseph Biskupiak, Michael Goodman, Scott Silverstein & Carl Asche. (2013) Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS–Kaposi’s sarcoma. Journal of Medical Economics 16:5, pages 606-613.
Read now
Russell Becker, Carole Dembek, Leigh Ann White & Louis P Garrison. (2012) The cost offsets and cost–effectiveness associated with pegylated drugs: a review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 775-793.
Read now
Francesca Cainelli & Alfredo Vallone. (2009) Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma. Biologics: Targets and Therapy 3, pages 385-390.
Read now

Articles from other publishers (8)

Esther E Freeman, Nicole C McCann, Aggrey Semeere, Krishna P Reddy, Miriam Laker-Oketta, Helen Byakwaga, Pamela P Pei, Maya E Hajny Fernandez, Samson Kiprono, Naftali Busakhala, Jeffery N Martin, Toby Maurer, Ingrid V Bassett, Kenneth A Freedberg & Emily P Hyle. (2022) Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis. The Lancet Global Health 10:8, pages e1179-e1188.
Crossref
Alessandro G. Campolina, Tania Y. Yuba, Tassia C. Decimoni, Roseli Leandro, Maria del Pilar Estevez Diz, Hillegonda M. D. Novaes & Patrícia C. de Soárez. (2018) Health Economic Evaluations of Cancer in Brazil: A Systematic Review. Frontiers in Public Health 6.
Crossref
Albert A. Mwafongo, Nora E. Rosenberg, Wingston Ng'ambi, Alexandra B. Werner, William M. Garneau, Joe Gumulira, Sam Phiri & Mina C. Hosseinipour. (2014) Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy. PLoS ONE 9:3, pages e91020.
Crossref
Rita Bosetti, Wim Marneffe & Lode Vereeck. (2013) Assessing the need for quality-adjusted cost–effectiveness studies of nanotechnological cancer therapies. Nanomedicine 8:3, pages 487-497.
Crossref
R Matthew Strother, Kamakshi V Rao, Kelly M Gregory, Beatrice Jakait, Naftali Busakhala, Ellen Schellhase, Sonak Pastakia, Monika Krzyzanowska & Patrick J Loehrer. (2012) The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya. Journal of Oncology Pharmacy Practice 18:4, pages 406-416.
Crossref
Karina Pupio Raimundo & Carl V. Asche. (2011) A review of the efficacy and outcomes studies of currently approved chemotherapy treatments for advanced AIDS-Kaposi's sarcoma. HIV & AIDS Review 10:3, pages 56-60.
Crossref
Tazio Vanni, Paula Mendes Luz, Rodrigo Antonini Ribeiro, Hillegonda Maria Dutilh Novaes & Carisi A. Polanczyk. (2009) Avaliação econômica em saúde: aplicações em doenças infecciosas. Cadernos de Saúde Pública 25:12, pages 2543-2552.
Crossref
Valesca P. Retèl, Marjan J.M. Hummel & Wim H. van Harten. (2009) Review on early technology assessments of nanotechnologies in oncology. Molecular Oncology 3:5-6, pages 394-401.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.